1-3 of 3
Jonathan L. Halperin
Close
Sort by
Journal Articles

Association of Bleeding Severity with Mortality with Extended Thromboprophylaxis in the Medically Ill in the Mariner Trial

Alex C. Spyropoulos, MD, Walter Ageno, Gregory W. Albers, MD, C. Gregory Elliott, MD, Jonathan L. Halperin, MD, William R. Hiatt, Gregory Maynard, MD, P. Gabriel Steg, MD, Jeffrey I. Weitz, MD, Theodore E. Spiro, MD, Wentao Lu, PhD, Chiara Sugarmann, BSN, MSHS, Concetta Lipardi, MD PhD, Gary E. Raskob, PhD, Elliot S. Barnathan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3669.
https://doi.org/10.1182/blood-2019-122621
Published: 2019
Journal Articles

Pilot/Feasibility Metrics, Real-Time Remote Monitoring, and Inter-Observer Agreement on Veno-Occlusion in a National Multicenter Randomized Controlled Trial of Pediatric Venous Thromboembolism: Findings from the Pilot/Feasibility Phase of the Kids-DOTT Trial

Neil A Goldenberg, MD PhD, Thomas C. Abshire, MD, Jonathan L Halperin, MD, William R. Hiatt, Craig M. Kessler, MD, John M Kittelson, PhD, Marilyn J. Manco-Johnson, MD, Alex Spyropoulos, MD, Phillipe Gabriel Steg, MD, Alexander G.G. Turpie, MD, Sam Schulman, MD PhD
Journal: Blood
Blood (2014) 124 (21): 4271.
https://doi.org/10.1182/blood.V124.21.4271.4271
Published: 2014
Journal Articles

Improving academic leadership and oversight in large industry-sponsored clinical trials: the ARO-CRO model

Clinical Trials & Observations
Neil A. Goldenberg, Alex C. Spyropoulos, Jonathan L. Halperin, Craig M. Kessler, Sam Schulman, Alexander G. G. Turpie, Allan M. Skene, Neal R. Cutler, William R. Hiatt, for the Antithrombotic Trials Leadership and Steering Group
Journal: Blood
Blood (2011) 117 (7): 2089–2092.
https://doi.org/10.1182/blood-2010-09-308858
Published: 2011